11:09 AM EDT, 07/15/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.81% to 1,482.50 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies Genfit ( GNFT ) and Grifols ( GRFS ) , which rose 4.5% and 1%, respectively. They were followed by 3D printer company Materialise (MTLS) and software firm SAP (SAP), which were up 0.5% and 0.3%, respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and telecommunications company Ericsson (ERIC), which dropped 12% and 6.5% respectively. They were followed by biotech firm Evaxion ( EVAX ) and biopharmaceutical company Cellectis ( CLLS ) , which lost 6.4% and 4.7% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana ( NCNA ) and pharmaceutical company Silence Therapeutics ( SLN ) , which advanced 7.4% and 2.2% respectively. They were followed by communications company WPP ( WPP ) and biopharmaceutical company Verona Pharma ( VRNA ) , which increased 1.6% and 0.1% respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which fell 5.3% and 4.4% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and biotech firm Trinity Biotech ( TRIB ) , which were down 3.8% and 2.6% respectively.